岳辰;马俊;杨沛青;康鹏德;沈彬;杨静;周宗科;朱芸;蔡东峰;裴福兴;

• 1:四川大学华西医院骨科

摘要(Abstract)：

[目的]探讨静脉10 mg/kg氨甲环酸减少同期双侧全髋关节置换术(total hip arthroplasty,THA)围术期失血的有效性及安全性。[方法]回顾四川大学华西医院2011年7月~2013年7月所有同期双侧全髋关节置换术,设定纳入排除标准后共纳入57例。其中静脉使用10 mg/kg氨甲环酸31例,未使用26例。氨甲环酸组患者于每侧手术切皮前均完成静脉单次使用10 mg/kg氨甲环酸,对照组不使用。对比术前及术后不同时间点血红蛋白(HB)值及红细胞压积(HCT)值的差异;根据Gross方程计算围术期总失血量;统计两组输血量及输血率;根据术后第5d双下肢静脉彩超结果判断术后深静脉血栓及肌间静脉血栓发生率,统计肺栓塞的发生率及术后住院天数,应用SPSS统计软件得出结论。[结果]氨甲环酸组术后1、3 d HB值及HCT值明显高于对照组,P<0.05,差异有统计学意义,但术后第5 d差异无统计学意义。氨甲环酸组围术期平均失血(1 811.6±490.8)ml,明显低于对照组(2 408.6±511.3)ml,P<0.05,差异有统计学意义。氨甲环酸组患者术后8例(25.8%,8/31),对照组14例(53.8%,14/26)输血,P<0.05,差异有统计学意义。氨甲环酸组人均输血量0.68 U,明显低于对照组1.23 U,P<0.05,差异有统计学意义。两组患者术后深静脉血栓、肌间静脉血栓、肺栓塞发生率及术后平均住院日比较差异无统计学意义。[结论]静脉单次10 mg/kg氨甲环酸于每侧关节置换前单次用药是控制同期双侧THA围术期失血安全、有效的方法。

关键词(KeyWords)： 氨甲环酸;同期双侧;全髋关节置换术;失血;输血;深静脉血栓

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目资助(编号:81271976/H0605、81171763和30772202/C1607)

作者(Author): 岳辰;马俊;杨沛青;康鹏德;沈彬;杨静;周宗科;朱芸;蔡东峰;裴福兴;

Email:

DOI:

参考文献(References)：

• [1]Lemaire R.Strategies for blood management in orthopaedic and trauma surgery[J].J Bone Joint Surg Br,2008,90:1128-1136.
• [2]Nilsson IM.Clinical pharmacology of aminocaproic and tranexamic acids[J].J Clin Pathol Suppl(Rcoll Pathol),1980,14:41-47.
• [3]Claeys MA,Vermeersch N,Haentjens P.Reduction of blood loss with tranexamic acids in primary total hip replacement surgery[J].Acta Chir Belg,2007,107:397-401.
• [4]Niskanen RO,Korkala OL.Tranexamic acid reduces blood loss in cemented hip arthroplasty:a randomized,double-blind study of 39 patients with osteoarthritis[J].Acta Orthop,2005,76:829-832.
• [5]Garneti N,Field J.Bone bleeding during total hip arthroplasty after administration of tranexamic acid[J].J Arthroplasty,2004,19:488-492.
• [6]Benoni G,Lethagen S,Nilsson P,et al.Tranexamic acid,given at the end of the operation,does not reduce postoperative blood loss in hip arthroplasty[J].Acta Orthop Scand,2000,71:250-254.
• [7]Benoni G,Fredin H,Knebel R,et al.Blood conservation with tranexamic acid in total hip arthroplasty:a randomized,double-blind study in 40 primary operations[J].Acta Orthop Scand,2001,72:442-448.
• [8]Ekbck G,Axelsson K,Ryttberg L,et al.Tranexamic acid reduces blood loss in total hip replacement surgery[J].Anesth Analg,2000,91:1124-1130.
• [9]Husted H,Blnd L,Sonne-Holm S,et al.Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty:a prospective randomized double blind study in 40 patients[J].Acta Orthop Scand,2003,74:665-669.
• [10]Johansson T,Pettersson LG,Lisander B.Tranexamic acid in total hip arthroplasty saves blood and money:a randomized,double-blind study in 100 patients[J].Acta Orthop,2005,76:314-319.
• [11]Lemay E,Guay J,CtéC,et al.Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement[J].Can J Anaesth,2004,51:31-37.
• [12]Yamasaki S,Masuhara K,Fuji T.Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases[J].Int Orthop,2004,28:69-73.
• [13]McConnell JS,Shewale S,Munro NA,et al.Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray.A randomized controlled trial[J].Acta Orthop,2011,6:660-663.
• [14]Rajesparan K,Biant LC,Ahmad M,et al.The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement[J].J Bone Joint Surg Br,2009,91-B:776-783.
• [15]Kazemi SM,Mosaffa F,Eajazi A,et al.The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia[J].Orthopedics,2010,1:17.
• [16]傅德杰,陈凯宁,杨柳.氨甲环酸对全膝关节置换术失血量影响的系统评价[J].中国矫形外科杂志,2012,13:1172-1177.
• [17]中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华关节外科杂志(电子版),2009,3:380-383.
• [18]Gross JB.Estimating allowable blood loss:corrected for dilution[J].Anaesthesiology,1983,58:277.
• [19]Sukeik M,Alshryda S,Haddad FS,et al.Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement[J].J Bone Joint Surg Br,2011,1:39-46.